Follow POL on Twitter Beck & Herrmann note an Eleventh Circuit case at the intersection of FDA pharmaceutical regulation and qui tam litigation.
"Off-Label Promotion and False Claims"
 |
| Isaac Gorodetski Project Manager, Center for Legal Policy at the Manhattan Institute igorodetski@manhattan-institute.org |
 |
| Bridget Carroll Press Officer, Manhattan Institute bcarroll@manhattan-institute.org |
